{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T00:21:16Z","timestamp":1793146876264,"version":"4.5.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","award":["REN20Q10"],"award-info":[{"award-number":["REN20Q10"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","award":["VANCIT23AO-LAD"],"award-info":[{"award-number":["VANCIT23AO-LAD"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","award":["BOAS23DO"],"award-info":[{"award-number":["BOAS23DO"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","award":["REN20QI0"],"award-info":[{"award-number":["REN20QI0"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","award":["VANCIT23A0-LAD"],"award-info":[{"award-number":["VANCIT23A0-LAD"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","award":["BOAS23D0"],"award-info":[{"award-number":["BOAS23D0"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","award":["NELSON20QI0"],"award-info":[{"award-number":["NELSON20QI0"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","cysticfibrosisjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cystic Fibrosis"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.jcf.2025.01.001","type":"journal-article","created":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T18:33:31Z","timestamp":1738262011000},"page":"660-666","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Impact of CFTR modulator therapy on basic life needs and financial concerns in people with cystic fibrosis: Data from the Well-ME survey"],"prefix":"10.1016","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-1874-303X","authenticated-orcid":false,"given":"Heather","family":"Boas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2961-5661","authenticated-orcid":false,"given":"Aricca D.","family":"Van Citters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth L.","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel R.","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily A.","family":"Zagnit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8218-1372","authenticated-orcid":false,"given":"Olivia","family":"Dieni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4431-0644","authenticated-orcid":false,"given":"Clement L.","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4922","key":"10.1016\/j.jcf.2025.01.001_bib0001","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1126\/science.2570460","article-title":"Identification of the cystic fibrosis gene: genetic analysis","volume":"245","author":"Kerem","year":"1989","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.jcf.2025.01.001_bib0002","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jcf.2008.09.007","article-title":"High treatment burden in adults with cystic fibrosis: challenges to disease self-management","volume":"8","author":"Sawicki","year":"2009","journal-title":"J Cyst Fibros"},{"issue":"9","key":"10.1016\/j.jcf.2025.01.001_bib0003","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1164\/rccm.200812-1845PP","article-title":"Cystic fibrosis pulmonary guidelines: treatment of pulmonary exacerbations","volume":"180","author":"Flume","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jcf.2025.01.001_bib0004","doi-asserted-by":"crossref","DOI":"10.1177\/17534666221086416","article-title":"Caregiver burden in cystic fibrosis: a systematic literature review","volume":"16","author":"Daly","year":"2022","journal-title":"Ther Adv Respir Dis"},{"issue":"7","key":"10.1016\/j.jcf.2025.01.001_bib0005","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1002\/ppul.25361","article-title":"Assessment of treatment burden and complexity in cystic fibrosis: a quality improvement project","volume":"56","author":"Hente","year":"2021","journal-title":"Pediatr Pulmonol"},{"issue":"3","key":"10.1016\/j.jcf.2025.01.001_bib0006","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.jcf.2019.10.025","article-title":"Characterising burden of treatment in cystic fibrosis to identify priority areas for clinical trials","volume":"19","author":"Davies","year":"2020","journal-title":"J Cyst Fibros"},{"issue":"9","key":"10.1016\/j.jcf.2025.01.001_bib0007","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1002\/ppul.25535","article-title":"Healthcare resource utilization and costs among children with cystic fibrosis in the united states","volume":"56","author":"Thorat","year":"2021","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jcf.2025.01.001_bib0008","article-title":"Measuring the burden of cystic fibrosis: a scoping review","author":"Cheema","year":"2023","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2025.01.001_bib0009","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1146\/annurev-med-042921-021447","article-title":"Cystic fibrosis modulator therapies","volume":"74","author":"Jia","year":"2023","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.jcf.2025.01.001_bib0010","series-title":"cystic fibrosis foundation patient registry highlights","year":"2023"},{"issue":"2","key":"10.1016\/j.jcf.2025.01.001_bib0011","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s40258-015-0211-4","article-title":"A scoping review of healthcare costs for patients with cystic fibrosis","volume":"14","author":"Hollin","year":"2016","journal-title":"Appl Health Econ Health Policy"},{"key":"10.1016\/j.jcf.2025.01.001_bib0012","article-title":"Wellness in the modulator era: an observational study of the impact of cftr modulator therapy on the well-being of people with cystic fibrosis","author":"Van Citters","year":"2024","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2025.01.001_bib0013","unstructured":"Hamel L.N.M,. Pollitz K., Levitt L., Claxton G., Brodie M. The burden of medical debt: results from the kaiser family foundation\/new york times medical bills survey. Kaiser Family Foundation \/New York Times; 2016 Jan 26 2022. https:\/\/www.kff.org\/health-costs\/report\/the-burden-of-medical-debt-results-from-the-kaiser-family-foundationnew-york-times-medical-bills-survey\/view\/print\/."},{"issue":"3","key":"10.1016\/j.jcf.2025.01.001_bib0014","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1002\/cncr.30369","article-title":"Measuring financial toxicity as a clinically relevant patient-reported outcome: the validation of the comprehensive score for financial toxicity (cost)","volume":"123","author":"de Souza","year":"2017","journal-title":"Cancer"},{"issue":"7","key":"10.1016\/j.jcf.2025.01.001_bib0015","first-page":"28","article-title":"The clinical global impressions scale: applying a research tool in clinical practice","volume":"4","author":"Busner","year":"2007","journal-title":"Psychiatry (Edgmont)"},{"key":"10.1016\/j.jcf.2025.01.001_bib0016","series-title":"Ibm spss statistics for mac","year":"2021"},{"key":"10.1016\/j.jcf.2025.01.001_bib0017","unstructured":"ATLAS.ti Scientific Software Development GmbH. Atlas.Ti mac. Version 23.3. 2024."},{"issue":"2","key":"10.1016\/j.jcf.2025.01.001_bib0018","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1191\/1478088706qp063oa","article-title":"Using thematic analysis in psychology","volume":"3","author":"Braun","year":"2006","journal-title":"Qual Res Psychol"},{"issue":"17","key":"10.1016\/j.jcf.2025.01.001_bib0019","article-title":"An overview of content analysis. Practical assessment","volume":"7","author":"Stemier","year":"2001","journal-title":"Res Eval"},{"issue":"1","key":"10.1016\/j.jcf.2025.01.001_bib0020","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/alr.22700","article-title":"Effect of highly effective modulator therapy on quality of life in adults with cystic fibrosis","volume":"11","author":"DiMango","year":"2021","journal-title":"Int Forum Allergy Rhinol"},{"issue":"21","key":"10.1016\/j.jcf.2025.01.001_bib0021","article-title":"Long-term follow-up of health-related quality of life and short-term intervention with cftr modulator therapy in adults with cystic fibrosis: evaluation of changes over several years with or without 33 weeks of cftr modulator therapy","volume":"11","author":"Gruber","year":"2023","journal-title":"Healthcare (Basel)"},{"issue":"1","key":"10.1016\/j.jcf.2025.01.001_bib0022","doi-asserted-by":"crossref","DOI":"10.1172\/JCI142239","article-title":"The discovery of insulin revisited: lessons for the modern era","volume":"131","author":"Lewis","year":"2021","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jcf.2025.01.001_bib0023","series-title":"Bittersweet: diabetes, insulin, and the transformation of illness","author":"Feudtner","year":"2004"},{"issue":"5","key":"10.1016\/j.jcf.2025.01.001_bib0024","doi-asserted-by":"crossref","first-page":"e295","DOI":"10.1016\/S2352-3018(23)00028-0","article-title":"Life expectancy after 2015 of adults with hiv on long-term antiretroviral therapy in europe and north america: a collaborative analysis of cohort studies","volume":"10","author":"Trickey","year":"2023","journal-title":"Lancet HIV"},{"issue":"3","key":"10.1016\/j.jcf.2025.01.001_bib0025","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1177\/1359105305051421","article-title":"The physical, emotional and interpersonal impact of haart: exploring the realities of hiv seropositive individuals on combination therapy","volume":"10","author":"Halkitis","year":"2005","journal-title":"J Health Psychol"},{"issue":"6","key":"10.1016\/j.jcf.2025.01.001_bib0026","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1002\/ppul.25285","article-title":"Cystic fibrosis patients of minority race and ethnicity less likely eligible for cftr modulators based on cftr genotype","volume":"56","author":"McGarry","year":"2021","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jcf.2025.01.001_bib0027","doi-asserted-by":"crossref","first-page":"S247","DOI":"10.1016\/S1569-1993(24)01298-0","article-title":"458 cost-cf: exploring financial stressors on daily life and access to care within the cf community","volume":"23","author":"Van Citters","year":"2024","journal-title":"J Cyst Fibros."}],"container-title":["Journal of Cystic Fibrosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199325000013?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199325000013?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T05:15:19Z","timestamp":1778822119000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1569199325000013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S1569199325000013"],"URL":"https:\/\/doi.org\/10.1016\/j.jcf.2025.01.001","relation":{},"ISSN":["1569-1993"],"issn-type":[{"value":"1569-1993","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of CFTR modulator therapy on basic life needs and financial concerns in people with cystic fibrosis: Data from the Well-ME survey","name":"articletitle","label":"Article Title"},{"value":"Journal of Cystic Fibrosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcf.2025.01.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}